MRI vs. Biopsy: Which Should Come First? @drstephenpetteruti
MRI vs. Biopsy: Which Should Come First?  @drstephenpetteruti
Uploaded July 2026 | Updated November 2026, 3 hours ago
An elevated PSA often leads to an important question: should you have a prostate biopsy right away, or is an MRI the better first step?

In this episode of Intellectual Medicine, Dr. Stephen Petteruti explains why multiparametric MRI has become an essential tool in evaluating men at risk for prostate cancer before proceeding to biopsy.

Dr. Petteruti discusses how MRI helps identify suspicious areas within the prostate, the role of the PI-RADS scoring system, and why imaging can provide valuable information that guides decision-making. He also explains the limitations of prostate biopsies, including sampling error and the challenge of drawing broad conclusions from a relatively small tissue sample.

The conversation explores how PSA trends, MRI findings, and clinical judgment work together to determine the most appropriate next steps. Dr. Petteruti also discusses active surveillance and emphasizes the importance of patients understanding their diagnostic options so they can make informed decisions in partnership with their physician.

Timestamps
(00:00) Elevated PSA: What's the next step?
(00:55) Why MRI often comes before biopsy
(01:45) What a prostate MRI can reveal
(02:20) Understanding the PI-RADS scoring system
(03:15) Why targeted biopsies have limitations
(05:20) What a biopsy can and cannot tell you
(07:20) Understanding Gleason scores and cancer grading
(09:15) When active surveillance may be appropriate
(11:10) Monitoring PSA and MRI over time
(12:20) Becoming an informed patient and making confident decisions

Enjoy the podcast? Subscribe and leave a 5-star review on your favorite platforms.

Dr. Stephen Petteruti is a board-certified physician specializing in longevity-focused, integrative medicine. He works with men navigating prostate cancer, testosterone, and hormone health, aging, and performance using proactive, evidence-informed strategies grounded in real clinical practice. His approach prioritizes preserving function, strength, and quality of life while helping patients make clear, informed decisions beyond reactive, fear-driven care.

πŸ“š Resources

Dr. Petteruti Men's Vitality Group
intellectualmedicine.com/membership

Fight Cancer Like a Man
amazon.com/Fight-Cancer-Like-Man-Breakthrough/dp/B0GP6JHQTQ

Dr. Petteruti's Newsletter
drstephenpetteruti.substack.com/subscribe

Podcast Show Notes
intellectualmedicine.com/podcast-notes

🌐 Learn More

Dr. Stephen Petteruti
drstephenpetteruti.com

Intellectual Medicine
intellectualmedicine.com

πŸ“± Connect with Dr. Petteruti

Instagram
instagram.com/dr.stephenpetteruti

Facebook
facebook.com/dr.stephenpetteruti

🎧 Listen to the Podcast

Apple Podcasts
podcasts.apple.com/us/podcast/intellectual-medicine/id1458649409

Spotify
open.spotify.com/show/3om1BQGP8f0hODZ6neWCd1

#Overdiagnosis #ProstateHealth #MensVitality #ActiveSurveillance

Disclaimer:
The content presented in this video reflects the opinions and clinical experience of Dr. Stephen Petteruti and is intended for informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional diagnosis, treatment, or guidance from your personal healthcare provider. Always consult your physician or qualified healthcare professional before making any changes to your health regimen or treatment plan
MRI vs. Biopsy: Which Should Come First?Your Gleason score does not dictate treatmentRadiation After Prostate Surgery: Should You Wait?Your Urologist Gets Paid to BiopsyShould You Get Your Insulin Level Tested?Know All Your Options Before You Choose SurgeryOne Simple Measurement Can Reveal Insulin ResistanceThe Cancer Treatment Oncologists Wont TouchIs Meat Bad for Prostate Cancer?Balancing Treatment Side Effects And Quality of Life.Who Funded the 270% Better Study?Stop Chasing Arbitrary PSA Numbers
Intellectual Medicine |

MRI vs. Biopsy: Which Should Come First?

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER